Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

Add To Watchlist

TSX:AEZS - Post Discussion

COSCIENS Biopharma Inc > Largest volume on NASDAQ since the close of the merger

View:

Post by prophetoffactz on Jul 09, 2024 2:18pm

Largest volume on NASDAQ since the close of the merger

and second largest volume on NASDAQ in the last year.

If AEZS announces compelling diagnostic results its forward plan gets a nice boost.

129

Comment

Comment by Schellaj on Jul 09, 2024 7:07pm

Hmm, I wonder why there are no comments from the consistently negative people.

Comment

Comment by tigerpro on Jul 10, 2024 12:29am

The CEO just wants to pump the stock price before shareholder meeting. Then he can be the board member and CEO forever. He did this several times before. He did the same thing before the merge vote several month ago. Old shareholders know this very well. New shareholders will be fooled again. So the CEO wish old shareholders sell their ...more

Comment

COSCIENS Biopharma Inc